값2022202320242025TTM판매비·일반관리비—————연구개발—————영업 이익—————비영업 수익, 합계—————이자비용(자본화한 이자 차감 후)—————이자비용을 제외한 비영업 수익—————비정상 수입/지출—————세전소득—————지분법 손익—————세금—————비지배 지분—————세후 기타 수익/비용—————중단된 사업 부문 제외 순이익—————중단된 사업—————순이익—————희석보정—————우선배당—————보통주주에게 귀속되는 희석 순이익—————주당 순이익(기본 EPS)—————희석 주당 순이익 (희석 EPS)—————평균 발행주식수—————희석주식수—————EBITDA—————EBIT—————매출원가—————기타 매출원가—————감가상각 및 무형자산 상각 (현금흐름)—————
Haleon plc American Depositary Shares (Each representing two Or
Haleon plc is a British multinational consumer healthcare company with headquarters in Weybridge, England. It is one of the largest consumer healthcare businesses in the world, with brands including Sensodyne toothpaste, Panadol and Advil painkillers, and Centrum vitamins. The company was projected to be a global leader in over the counter medicines with a 7.3 per cent market share in 2022.
Haleon was established on 18 July 2022 as a corporate spin-off from GSK. Haleon is listed on the London Stock Exchange and is a component of the FTSE 100, with a secondary listing on the New York Stock Exchange.